Cargando…
Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda
Schistosomiasis is a parasitic infection highly prevalent in sub-Saharan Africa, and a significant cause of morbidity; it is a priority for vaccine development. A controlled human infection model for Schistosoma mansoni (CHI-S) with potential to accelerate vaccine development has been developed amon...
Autores principales: | Koopman, Jan Pieter, Egesa, Moses, Wajja, Anne, Adriko, Moses, Nassuuna, Jacent, Nkurunungi, Gyaviira, Driciru, Emmanuella, van Willigen, Gijsbert, Cose, Stephen, Yazdanbakhsh, Maria, Kaleebu, Pontiano, Kabatereine, Narcis, Tukahebwa, Edridah, Roestenberg, Meta, Elliott, Alison M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901351/ https://www.ncbi.nlm.nih.gov/pubmed/31819922 http://dx.doi.org/10.12688/aasopenres.12972.2 |
Ejemplares similares
-
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
por: Abaasa, Andrew, et al.
Publicado: (2023) -
Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders’ meeting held in Entebbe, Uganda.
por: Elliott, Alison M., et al.
Publicado: (2018) -
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda
por: Egesa, Moses, et al.
Publicado: (2022) -
Impact of a national deworming campaign on the prevalence of soil-transmitted helminthiasis in Uganda (2004-2016): Implications for national control programs
por: Adriko, Moses, et al.
Publicado: (2018) -
Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings
por: Driciru, Emmanuella, et al.
Publicado: (2021)